Epithalon
Also known as: Epitalon · Epithalone · AE-0 peptide
Epithalon is a synthetic tetrapeptide derived from a pineal gland peptide, extensively studied in preclinical research for its potential geroprotective effects, including modulation of telomerase activity and neuroendocrine functions. It is a research compound and is not FDA-approved for human use.
What is Epithalon?
Epithalon, also known as Epitalon or AE-0 peptide, is a synthetic tetrapeptide modeled after a naturally occurring peptide complex found in the pineal gland. Initially synthesized based on the amino acid composition of Epithalamin, a bovine pineal extract, Epithalon was designed to replicate and enhance the biological activities of these endogenous peptides.
Since its discovery, Epithalon has been extensively investigated across various preclinical models including in vitro, in vivo, and in silico studies. Researchers focus on this peptide due to its reported geroprotective properties and ability to influence neuroendocrine regulation, particularly via modulation of melatonin synthesis and immune signaling pathways.
The compound’s utility in laboratory research is primarily centered on its effects on aging-related molecular processes, including enhancement of telomerase activity, antioxidant defenses, and enzyme function. Epithalon remains a research-use-only substance, with no regulatory approval for clinical or therapeutic application.
Its chemical identity is well defined, with a molecular formula of C14H22N4O9 and a molecular weight of 390.35 g/mol (PubChem CID 219042). This specificity facilitates detailed biochemical and pharmacodynamic investigations in multiple experimental contexts.
Key Benefits & Mechanisms
- Geroprotective EffectsPreclinical studies have demonstrated that Epithalon exhibits geroprotective properties by modulating cellular aging processes. Its ability to enhance telomerase activity supports maintenance of telomere length, which is associated with delayed cellular senescence and improved longevity markers in animal models.
- Neuroendocrine ModulationEpithalon influences neuroendocrine functions by directly affecting melatonin synthesis in the pineal gland and altering mRNA expression of interleukin-2, a key cytokine involved in immune regulation. These actions suggest a role in modulating circadian rhythms and immune responses relevant to aging.
- Antioxidant and Neuroprotective ActionsResearch indicates that Epithalon enhances the activity of enzymes such as acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), which may contribute to its neuroprotective effects. Its antioxidant properties help reduce oxidative stress, a known contributor to age-related cellular damage.
- Antimutagenic PropertiesEpithalon has shown antimutagenic effects in preclinical models, which may reduce the accumulation of genetic mutations associated with aging and disease. This contributes to its potential role in maintaining genomic stability over time.
- Circadian and Mitochondrial RegulationStudies have suggested that Epithalon, alongside other peptides, targets circadian regulators and mitochondrial function. This may help improve cellular energy metabolism and synchronize biological rhythms, which are often disrupted during aging.
Mechanism of action
Epithalon exerts its mechanism of action through multiple interrelated pathways. It directly influences melatonin synthesis within the pineal gland, thereby modulating circadian and neuroendocrine functions. Additionally, it alters the mRNA levels of interleukin-2, implicating an immunomodulatory role. Epithalon enhances the activity of several key enzymes, including acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and notably telomerase, which is critical for telomere elongation and genomic stability. These enzymatic effects contribute to its antioxidant, neuroprotective, and antimutagenic properties. While these pathways collectively underpin its geroprotective effects, the precise molecular mechanisms remain incompletely characterized and are an ongoing subject of research.
Research Summary
Research into Epithalon encompasses diverse studies that elucidate its biological activities and potential applications. Key findings from recent literature include:
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions (2026)
This review highlights Epithalon among other peptides as a recovery-enhancing agent targeting circadian and mitochondrial regulators. It situates Epithalon within the broader context of peptides that modulate molecular signaling to promote tissue regeneration and neuromuscular recovery, although clinical trials remain limited.
Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties (2025)
This comprehensive review details Epithalon’s synthesis based on pineal peptides and summarizes 25 years of in vitro, in vivo, and in silico studies. It emphasizes its geroprotective, neuroendocrine, antioxidant, and antimutagenic effects, while noting the limited physico-chemical and structural data available. The review underscores the complexity of its mechanism of action and the need for further mechanistic elucidation.
Aging of the Pineal Gland (2002)
This study reports age-related functional changes in the pineal gland that may be mitigated by Epithalon administration. It documents increased nocturnal melatonin peaks and life extension effects in animal models treated with Epithalon. The authors propose that Epithalon’s targets may include transcription factors specific to the pineal gland and retina, which decline in function with age.
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. (2026) PubMed · PMID 41490200
- Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. (2025) PubMed · PMID 40141333
- [Aging of the pineal gland]. (2002) PubMed · PMID 12096440
Dosing in Research Literature
Published research on Epithalon includes a variety of dosing protocols primarily in animal models. However, precise and standardized dosing regimens for this compound are not well established in the literature. Doses used in preclinical studies vary widely depending on the experimental design, species, and endpoints assessed.
Typically, dosing in animal studies involves administration routes such as intraperitoneal or subcutaneous injections, with treatment durations ranging from days to weeks to evaluate effects on aging markers, telomerase activity, and neuroendocrine parameters. Due to the absence of clinical trials and regulatory approval, no consensus exists on optimal dosing protocols for human research contexts.
The figures above describe doses reported in published or preclinical research, provided for context only. This is not medical advice or a dosing recommendation, and these compounds are not approved for human use.
Common Stacks
Frequently asked questions about Epithalon
Is Epithalon approved by the FDA for medical use?
Epithalon is not approved by the U.S. Food and Drug Administration (FDA) for any medical or therapeutic use. It is classified as a research compound and is intended solely for laboratory and preclinical investigations.
What is the primary focus of Epithalon research?
Research on Epithalon primarily focuses on its potential geroprotective effects, including its ability to modulate telomerase activity, influence melatonin synthesis, and exert antioxidant and neuroprotective actions relevant to aging and longevity.
How does Epithalon work at the molecular level?
Epithalon acts via multiple molecular pathways, including direct stimulation of melatonin production, modulation of interleukin-2 mRNA expression, and enhancement of enzymes such as telomerase, acetylcholinesterase, and butyrylcholinesterase. These combined actions contribute to its antioxidant, neuroprotective, and antimutagenic effects observed in preclinical studies.
Can Epithalon be combined with other peptides in research?
Yes, Epithalon is often studied in combination with other peptides such as CJC-1295, Ipamorelin, and Selank to explore synergistic effects on aging, tissue regeneration, neuroprotection, and hormonal regulation within preclinical models.
What are the storage and handling considerations for Epithalon?
As a synthetic peptide, Epithalon should be stored under conditions that preserve its stability, typically refrigerated or frozen as recommended by the manufacturer or supplier. Proper handling to avoid degradation, including protection from repeated freeze-thaw cycles and exposure to moisture, is essential in research settings.
Legal & research status: Research use only — not approved by the FDA for human use. Sold and discussed for laboratory and research use only, not for human consumption.